Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Glaxo, Colgate, Bid on Pfizer Products - Happi
Company News

Glaxo, Colgate, Bid on Pfizer Products

GlaxoSmithKline Plc and Colgate-Palmolive Co. are among companies expected to submit offers for Pfizer Inc’s array of consumer products in first-round bidding, according to the Wall Street Journal.

Pfizer, New York, NY, hopes to gain about $14 billion for the products, representatives noted. The products include Bengay pain-reliever cream, Sudafed cold tablets and Listerine mouthwash. Pfizer acquired many of its consumer brands in 2000 from its merger with Warner-Lambert Co.

Last month, Pfizer said that it was planning to sell or spin off its consumer products division, which had sales of $3.88 billion last year. There was speculation that bidders could include Glaxo or U.S.-based Colgate.

In a conference, Colgate chief operating officer Ian Cook said that Listerine was strategically right and that Colgate would look at buying the brand “very, very aggressively.” Jean-Pierre Garnier, Glaxo chief executive, said he would consider the Pfizer consumer healthcare business but there was no guarantee of a bid.

Industry analysts said other potential bidders could include Swiss drugmaker Novartis AG and Britain’s Reckitt Benckiser Plc.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters